Top compounds associated with response to FXYD2


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.5
mRNA simvastatin CTRPv2 pan-cancer AAC -0.028 0.5
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.023 0.5
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.025 0.5
mRNA Curcumin CTRPv2 pan-cancer AAC 0.024 0.5
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.026 0.5
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.026 0.5
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.027 0.5
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.022 0.5
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.03 0.5
Download CSV